Citations (88)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (3)
Josep Darbà & Alicia Marsà. (2021) Analysis of hospital incidence and direct medical costs of intrahepatic cholangiocarcinoma in Spain (2000-2018). Expert Review of Pharmacoeconomics & Outcomes Research 21:3, pages 425-431.
Read now
Read now
Yong-Na Wu, Li-Hong He, Zhong-Tian Bai & Xun Li. (2020) NRP1 is a Prognostic Factor and Promotes the Growth and Migration of Cells in Intrahepatic Cholangiocarcinoma. Cancer Management and Research 12, pages 7021-7032.
Read now
Read now
Malcolm H. Squires, Jordan M. Cloyd, Mary Dillhoff, Carl Schmidt & Timothy M. Pawlik. (2018) Challenges of surgical management of intrahepatic cholangiocarcinoma. Expert Review of Gastroenterology & Hepatology 12:7, pages 671-681.
Read now
Read now
Articles from other publishers (85)
Satoshi Eguchi, Daisaku Yamada, Shogo Kobayashi, Kazuki Sasaki, Yoshifumi Iwagami, Yoshito Tomimaru, Takehiro Noda, Hidenori Takahashi, Tadafumi Asaoka, Masahiro Tanemura, Yuichiro Doki & Hidetoshi Eguchi. (2023) Automated Analysis for the Prevalence of Cancer-Associated Fibroblasts in Resected Specimens of Intrahepatic Cholangiocarcinoma is a Simple and Reliable Evaluation System. Annals of Surgical Oncology.
Crossref
Crossref
Zijiao Yang & Xia Jiang. (2023) Efficacy and safety comparison of neoadjuvant chemotherapy followed by surgery and upfront surgery for treating intrahepatic cholangiocarcinoma: a systematic review and meta-analysis. BMC Gastroenterology 23:1.
Crossref
Crossref
Anne-Marleen van Keulen, Stefan Büttner, Joris I. Erdmann, Jeroen Hagendoorn, Frederik J.H. Hoogwater, Jan N.M. IJzermans, Ulf P. Neumann, Wojciech G. Polak, Jeroen De Jonge, Pim B. Olthof & Bas Groot Koerkamp. (2023) Major complications and mortality after resection of intrahepatic cholangiocarcinoma: A systematic review and meta-analysis. Surgery 173:4, pages 973-982.
Crossref
Crossref
Peng Wan, Haiyan Xue, Chunrui Liu, Fang Chen, Wei Shao, Jing Qin, Wentao Kong & Daoqiang Zhang. (2023) Transport-Based Anatomical-Functional Metric Learning for Liver Tumor Recognition Using Dual-View Dynamic CEUS Imaging. IEEE Transactions on Biomedical Engineering 70:3, pages 1012-1023.
Crossref
Crossref
Tomohiko Taniai, Koichiro Haruki, Mitsuru Yanagaki, Yosuke Igarashi, Kenei Furukawa, Shinji Onda, Jungo Yasuda, Michinori Matsumoto, Masashi Tsunematsu & Toru Ikegami. (2022) Osteosarcopenia predicts poor prognosis for patients with intrahepatic cholangiocarcinoma after hepatic resection. Surgery Today 53:1, pages 82-89.
Crossref
Crossref
Chanza F. Shaikh, Laura Alaimo, Zorays Moazzam, Yutaka Endo, Henrique A. Lima, Zaiba Dawood, Muhammad M. Munir & Timothy M. Pawlik. (2022) Predicting overall and recurrence‐free survival in patients with intrahepatic cholangiocarcinoma using the MEGNA score: A multi‐institutional analysis. Journal of Surgical Oncology 127:1, pages 73-80.
Crossref
Crossref
Hisashi Kosaka, Mitsuaki Ishida, Masaki Ueno, Koji Komeda, Daisuke Hokutou, Hiroya Iida, Fumitoshi Hirokawa, Kosuke Matsui, Mitsugu Sekimoto & Masaki Kaibori. (2022) Tumor budding may be a promising prognostic indicator in intrahepatic cholangiocarcinoma: A multicenter retrospective study. Annals of Gastroenterological Surgery 7:1, pages 138-146.
Crossref
Crossref
Jun Li, Jiongjiong Lu, Shaodong Lv, Shujun Sun, Caifeng Liu, Feng Xu, Haiying Sun, Jiamei Yang, Xinjun Wang, Xingyang Zhong & Junhua Lu. (2022) Linoleic acid pathway disturbance contributing to potential cancerization of intrahepatic bile duct stones into intrahepatic cholangiocarcinoma. BMC Gastroenterology 22:1.
Crossref
Crossref
Masaki Kaibori, Kengo Yoshii, Hisashi Kosaka, Masato Ota, Koji Komeda, Masaki Ueno, Daisuke Hokutou, Hiroya Iida, Kosuke Matsui & Mitsugu Sekimoto. (2022) Preoperative Serum Markers and Risk Classification in Intrahepatic Cholangiocarcinoma: A Multicenter Retrospective Study. Cancers 14:21, pages 5459.
Crossref
Crossref
Rebecca Marcus, Wade Christopher, Jennifer Keller, Sean Nassoiy, Shu-Ching Chang, Melanie Goldfarb, Ronald Wolf & Zeljka Jutric. (2022) Systemic Therapy Is Associated with Improved Oncologic Outcomes in Resectable Stage II/III Intrahepatic Cholangiocarcinoma: An Examination of the National Cancer Database over the Past Decade. Cancers 14:17, pages 4320.
Crossref
Crossref
Jessica J. Holster, Marouan El Hassnaoui, Stijn Franssen, Jan N. M. IJzermans, Jeroen de Jonge, Bianca Mostert, Wojciech G. Polak, Roeland F. de Wilde, Marjolein Y. V. Homs & Bas Groot Koerkamp. (2022) Hepatic Arterial Infusion Pump Chemotherapy for Unresectable Intrahepatic Cholangiocarcinoma: A Systematic Review and Meta-Analysis. Annals of Surgical Oncology 29:9, pages 5528-5538.
Crossref
Crossref
Yao Xiao, Baoluhe Zhang, Jordan M. Cloyd, Laura Alaimo, Gang Xu, Shunda Du, Yilei Mao & Timothy M. Pawlik. (2022) Novel Drug Candidate Prediction for Intrahepatic Cholangiocarcinoma via Hub Gene Network Analysis and Connectivity Mapping. Cancers 14:13, pages 3284.
Crossref
Crossref
Qi Li, Jian Zhang, Chen Chen, Tianqiang Song, Yinghe Qiu, Xianhai Mao, Hong Wu, Yu He, Zhangjun Cheng, Wenlong Zhai, Jingdong Li, Dong Zhang, Zhimin Geng & Zhaohui Tang. (2022) A Nomogram Model to Predict Early Recurrence of Patients With Intrahepatic Cholangiocarcinoma for Adjuvant Chemotherapy Guidance: A Multi-Institutional Analysis. Frontiers in Oncology 12.
Crossref
Crossref
Shuang-Nan Zhou, Shan-Shan Lu, Da-Wei Ju, Ling-Xiang Yu, Xiao-Xiao Liang, Xiao Xiang, Suthat Liangpunsakul, Lewis R. Roberts, Yin-Ying Lu & Ning Zhang. (2021) A New Prognostic Model Covering All Stages of Intrahepatic Cholangiocarcinoma. Journal of Clinical and Translational Hepatology 10:2, pages 254-262.
Crossref
Crossref
Baran Umut Vardar, Carolyn S. Dupuis, Alan J. Goldstein, Zeynep Vardar & Young H. Kim. (2022) Ultrasonographic evaluation of patients with abnormal liver function tests in the emergency department. Ultrasonography 41:2, pages 243-262.
Crossref
Crossref
Taek Chung & Young Nyun Park. (2022) Up-to-Date Pathologic Classification and Molecular Characteristics of Intrahepatic Cholangiocarcinoma. Frontiers in Medicine 9.
Crossref
Crossref
Sathish K. Krishnan, Karattupalayam S. Mouleeswaran, Prasanna Gopal, Rajanikanth Patcha, Somashekara H. Ramakrishna, Perumal Karnan, Selvakumar Malleeswaran, Joy Varghese & Mettu S. Reddy. (2022) First Report of a Paediatric Collision Tumour in the Liver Recognised After Liver Transplantation: Blissful Ignorance Has Benefits!. Journal of Clinical and Experimental Hepatology 12:2, pages 696-700.
Crossref
Crossref
Richard X. Sousa Da Silva, Beat Muellhaupt, Philipp Dutkowski & Pierre-Alain Clavien. (2022) Liver transplantation for malignant liver tumors. iLIVER 1:1, pages 3-11.
Crossref
Crossref
Hisashi Kosaka, Masaki Ueno, Koji Komeda, Daisuke Hokuto, Hiroya Iida, Fumitoshi Hirokawa, Kosuke Matsui, Mitsugu Sekimoto & Masaki Kaibori. (2022) The Impact of a Preoperative Staging System on Accurate Prediction of Prognosis in Intrahepatic Cholangiocarcinoma. Cancers 14:5, pages 1107.
Crossref
Crossref
Guanran Zhang, Xuyue Liu, Zhengyang Sun, Xiaoning Feng, Haiyan Wang, Jing Hao & Xiaoli Zhang. (2022) A2M is a potential core gene in intrahepatic cholangiocarcinoma. BMC Cancer 22:1.
Crossref
Crossref
Narisara Phansila, Chaiyasit Sittiwet & Ranee Wongkongdech. (2022) Comparison of effects of medicinal cannabis or standard palliative care on quality of life of patients with cholangiocarcinoma in Northeast Thailand. F1000Research 11, pages 20.
Crossref
Crossref
Ki-Hun Kim & Jeong-Ik Park. 2022. Hepato-Pancreato-Biliary Malignancies. Hepato-Pancreato-Biliary Malignancies
325
331
.
Michael J. Breen, Osman S. Ahmed, Joshua Owen & Chih-Yi Liao. 2022. Hepato-Pancreato-Biliary Malignancies. Hepato-Pancreato-Biliary Malignancies
307
323
.
Cindy Wang & Namrata Setia. 2022. Hepato-Pancreato-Biliary Malignancies. Hepato-Pancreato-Biliary Malignancies
295
306
.
Viktoriia A. Arzumanian, Olga I. Kiseleva & Ekaterina V. Poverennaya. (2021) The Curious Case of the HepG2 Cell Line: 40 Years of Expertise. International Journal of Molecular Sciences 22:23, pages 13135.
Crossref
Crossref
Yong Tang, Chun Mei Yang, Song Su, Wei Jia Wang, Li Ping Fan & Jian Shu. (2021) Machine learning-based Radiomics analysis for differentiation degree and lymphatic node metastasis of extrahepatic cholangiocarcinoma. BMC Cancer 21:1.
Crossref
Crossref
Rebecca Marcus, Sammy Ferri-Borgogno, Abdel Hosein, Wai Chin Foo, Bidyut Ghosh, Jun Zhao, Kimal Rajapakshe, James Brugarolas, Anirban Maitra & Sonal Gupta. (2021) Oncogenic KRAS Requires Complete Loss of BAP1 Function for Development of Murine Intrahepatic Cholangiocarcinoma. Cancers 13:22, pages 5709.
Crossref
Crossref
Tingming Liang, Lulu Shen, Yaya Ji, Lin Jia, Yuyang Dou & Li Guo. (2021) NOV/CCN3 Promotes Cell Migration and Invasion in Intrahepatic Cholangiocarcinoma via miR-92a-3p. Genes 12:11, pages 1659.
Crossref
Crossref
Ioannis A. Ziogas, Stepan M. Esagian, Dimitrios Giannis, Muhammad H. Hayat, Dimitrios Kosmidis, Lea K. Matsuoka, Martin I. Montenovo, Georgios Tsoulfas, David A. Geller & Sophoclis P. Alexopoulos. (2021) Laparoscopic versus open hepatectomy for intrahepatic cholangiocarcinoma: An individual patient data survival meta-analysis. The American Journal of Surgery 222:4, pages 731-738.
Crossref
Crossref
Rishi Philip Mathew, Teena Sleeba, Latha K. Abraham, Sanju Cyriac & Ajith Toms. (2021) PAX8-Positive Intrahepatic Cholangiocarcinoma—a Rare and Hardly Recognized Entity. Journal of Gastrointestinal Cancer 52:3, pages 1102-1105.
Crossref
Crossref
Li-Ming Deng, Yi Wang, Jin-Huan Yang, Jia-Liang Li, Zi-Yan Chen, Wen-Ming Bao, Kai-Yu Chen, Xin-Fei Yao, Chong-Ming Zheng, Jiu-Yi Zheng, Zheng-Ping Yu, Bin Jin & Gang Chen. (2021) Diffuse reduction of spleen density is a novel prognostic marker for intrahepatic cholangiocarcinoma after curative resection. World Journal of Gastrointestinal Oncology 13:8, pages 929-942.
Crossref
Crossref
Luke Boulter & Mo R. Ebrahimkhani. (2021) Build to understand biliary oncogenesis via organoids and FGFR2 fusion proteins. Journal of Hepatology 75:2, pages 262-264.
Crossref
Crossref
Linlin Yin, Si Zhao, Hanlong Zhu, Guozhong Ji & Xiuhua Zhang. (2021) Primary tumor resection improves survival in patients with multifocal intrahepatic cholangiocarcinoma based on a population study. Scientific Reports 11:1.
Crossref
Crossref
Xiaoyan Liao & Dongwei Zhang. (2020) The 8th Edition American Joint Committee on Cancer Staging for Hepato-pancreato-biliary Cancer: A Review and Update. Archives of Pathology & Laboratory Medicine 145:5, pages 543-553.
Crossref
Crossref
Ovie Utuama, Jennifer B. Permuth, Getachew Dagne, Aurora Sanchez-Anguiano, Amy Alman, Ambuj Kumar, Jason Denbo, Richard Kim, Jason B. Fleming & Daniel A. Anaya. (2021) Neoadjuvant Chemotherapy for Intrahepatic Cholangiocarcinoma: A Propensity Score Survival Analysis Supporting Use in Patients with High-Risk Disease. Annals of Surgical Oncology 28:4, pages 1939-1949.
Crossref
Crossref
Dana Balitzer & Sanjay Kakar. (2021) Challenges in Diagnosis of Hepatocellular Carcinoma in Cirrhotic Liver: A Pathologist’s Perspective. Clinical Liver Disease 17:4, pages 249-254.
Crossref
Crossref
Jonathan J. Hue, Flavio G. Rocha, John B. Ammori, Jeffrey M. Hardacre, Luke D. Rothermel, Kenneth D. Chavin, Jordan M. Winter & Lee M. Ocuin. (2021) A comparison of surgical resection and liver transplantation in the treatment of intrahepatic cholangiocarcinoma in the era of modern chemotherapy: An analysis of the National Cancer Database. Journal of Surgical Oncology 123:4, pages 949-956.
Crossref
Crossref
Yuan Zhang, Lufei Zhang, Sinan Lu, Yucheng Xiang, Cheng Zeng, Tianyu He, Yuan Ding & Weilin Wang. (2021) Long Non-coding RNA CASC15 Promotes Intrahepatic Cholangiocarcinoma Possibly through Inducing PRDX2/PI3K/AKT Axis. Cancer Research and Treatment 53:1, pages 184-198.
Crossref
Crossref
Yasar Ahmed, Raza Khan, Mary O’Reilly, Shane O’Sulivan & Thamir Mahgoub. (2021) FGFR inhibitors: Emerging treatments in advanced or metastatic cholangiocarcinoma. Journal of Current Oncology 4:1, pages 22.
Crossref
Crossref
Qian Yu, Chenyu Liu, Anjana Pillai & Osman Ahmed. (2021) Twenty Years of Radiation Therapy of Unresectable Intrahepatic Cholangiocarinoma: Internal or External? A Systematic Review and Meta-Analysis. Liver Cancer 10:5, pages 433-450.
Crossref
Crossref
Alphonse E. Sirica, Mario Strazzabosco & Massimiliano Cadamuro. 2021. Mechanisms and Therapy of Liver Cancer. Mechanisms and Therapy of Liver Cancer
321
387
.
Ki-Hun Kim & Jeong-Ik Park. 2021. Hepato-Pancreato-Biliary Malignancies. Hepato-Pancreato-Biliary Malignancies
1
7
.
Michael J. Breen, Osman S. Ahmed, Joshua Owen & Chih-Yi Liao. 2021. Hepato-Pancreato-Biliary Malignancies. Hepato-Pancreato-Biliary Malignancies
1
17
.
Cindy Wang & Namrata Setia. 2021. Hepato-Pancreato-Biliary Malignancies. Hepato-Pancreato-Biliary Malignancies
1
12
.
Takuya Yamamoto, Tomoyuki Abe, Akihiko Oshita, Shuji Yonehara, Yoshio Katamura, Nozomu Matsumoto, Tsuyoshi Kobayashi, Masahiro Nakahara, Hideki Ohdan & Toshio Noriyuki. (2020) Intrahepatic cholangiocarcinoma with clear cell type following laparoscopic curative surgery. Surgical Case Reports 6:1.
Crossref
Crossref
Pouya Entezari & Ahsun Riaz. (2020) Intrahepatic Cholangiocarcinoma. Seminars in Interventional Radiology 37:05, pages 475-483.
Crossref
Crossref
Nicole Cheng, Nathanelle Khoo, Alexander Y. F. Chung, Brian K. P. Goh, Peng Chung Cheow, Pierce K. H. Chow, Ser Yee Lee, London L. Ooi, Prema Raj Jeyaraj, Juinn Huar Kam, Ye Xin Koh, Chung Yip Chan & Jin Yao Teo. (2020) Pre-operative Imaging Characteristics in Histology-Proven Resected Intrahepatic Cholangiocarcinoma. World Journal of Surgery 44:11, pages 3862-3867.
Crossref
Crossref
Mohammed Saleh, Mayur Virarkar, Vlad Bura, Raul Valenzuela, Sanaz Javadi, Janio Szklaruk & Priya Bhosale. (2020) Intrahepatic cholangiocarcinoma: pathogenesis, current staging, and radiological findings. Abdominal Radiology 45:11, pages 3662-3680.
Crossref
Crossref
B. N. Gurmikov, O. I. Zhavoronkova, Yu. A. Stepanova, V. A. Vishnevsky & A. V. Chzhao. (2020) Radiofrequency ablation of intrahepatic cholangiocarcinoma (clinical observation). Annaly khirurgicheskoy gepatologii = Annals of HPB Surgery 25:3, pages 142-148.
Crossref
Crossref
Vivek Sukumar, Shraddha Patkar, Mahesh Goel & Ayushi Sahay. (2020) Intrahepatic Cholangiocarcinoma Presenting as a Scalp Mass. Journal of Gastrointestinal Cancer 51:3, pages 1044-1046.
Crossref
Crossref
Juan C. Mejia & Jennifer Pasko. (2020) Primary Liver Cancers. Surgical Clinics of North America 100:3, pages 535-549.
Crossref
Crossref
Nikolaos Machairas, Hauke Lang, Kumar Jayant, Dimitri A. Raptis & Georgios C. Sotiropoulos. (2020) Intrahepatic cholangiocarcinoma: Limitations for resectability, current surgical concepts and future perspectives. European Journal of Surgical Oncology 46:5, pages 740-746.
Crossref
Crossref
Christopher Coon, Nicholas Berger, Dan Eastwood, Susan Tsai, Kathleen Christians, Harveshp Mogal, Callisia Clarke & T. Clark Gamblin. (2019) Primary Liver Cancer: An NCDB Analysis of Overall Survival and Margins After Hepatectomy. Annals of Surgical Oncology 27:4, pages 1156-1163.
Crossref
Crossref
Diamantis I. Tsilimigras, Rittal Mehta, Luca Aldrighetti, George A. Poultsides, Shishir K. Maithel, Guillaume Martel, Feng Shen, Bas Groot Koerkamp, Itaru Endo, Timothy M. Pawlik, Anghela Z. Paredes, Dimitrios Moris, Kota Sahara, Fabio Bagante, Alfredo Guglielmi, Matthew Weiss, Todd W. Bauer, Sorin Alexandrescu, Hugo P. Marques, Carlo Pulitano, Olivier Soubrane, Jordan M. Cloyd & Aslam Ejaz. (2020) Development and Validation of a Laboratory Risk Score (LabScore) to Predict Outcomes after Resection for Intrahepatic Cholangiocarcinoma. Journal of the American College of Surgeons 230:4, pages 381-391e2.
Crossref
Crossref
Anando Sen, Brian M. Anderson, Guillaume Cazoulat, Molly M. McCulloch, Dalia Elganainy, Brigid A. McDonald, Yulun He, Abdallah S. R. Mohamed, Baher A. Elgohari, Mohamed Zaid, Eugene J. Koay & Kristy K. Brock. (2020) Accuracy of deformable image registration techniques for alignment of longitudinal cholangiocarcinoma CT images. Medical Physics 47:4, pages 1670-1679.
Crossref
Crossref
A. V. Chzhao, B. N. Gurmikov, V. A. Vishnevsky, A. A. Olifir, Ya. Ya. Gavrilov, L. A. Marinova & U. D. Usmonov. (2020) Two-stage liver resection for intrahepatic cholangiocarcinoma. Annaly khirurgicheskoy gepatologii = Annals of HPB Surgery 25:1, pages 106-112.
Crossref
Crossref
Xiaodong Jia, Shanshan Lu, Zhen Zeng, Qingyan Liu, Zheng Dong, Yan Chen, Zhenyu Zhu, Zhixian Hong, Ting Zhang, Guifang Du, Jiao Xiang, Dawei Wu, Wenlin Bai, Bin Yang, Yinyin Li, Jiagan Huang, Haiyang Li, Rifaat Safadi & Yinying Lu. (2019) Characterization of Gut Microbiota, Bile Acid Metabolism, and Cytokines in Intrahepatic Cholangiocarcinoma. Hepatology 71:3, pages 893-906.
Crossref
Crossref
Quanxing Hong, Jiahui Zhou, Zhongping Zhang, Weiwei Chen, Guoqiang Wei, Hao Huang & Yun Yu. (2020) Label-free screening of intrahepatic cholangiocarcinoma cells using electroporation assisted surface-enhanced Raman scattering combined with statistical algorithms. Laser Physics 30:2, pages 025601.
Crossref
Crossref
Chunmei Yang, Mengping Huang, Shupan Li, Jianqiang Chen, Yao Yang, Na Qin, Deqing Huang & Jian Shu. (2020) Radiomics model of magnetic resonance imaging for predicting pathological grading and lymph node metastases of extrahepatic cholangiocarcinoma. Cancer Letters 470, pages 1-7.
Crossref
Crossref
Olivia Grubman, Dyese Taylor, Madhavi Rayapudi & Lois Brustman. (2020) A case report of a pregnant woman diagnosed with intrahepatic cholangiocarcinoma (ICC) complicated by opioid tolerance. Case Reports in Perinatal Medicine 9:1.
Crossref
Crossref
Shaoping Chen, Jianmei Yang, Xin Gao, Qiang Liu, Xunguo Wang, Yanchun Guo, Ruibao Liu & Fang Wang. (2020) Different administration methods of endostar combined with second-line chemotherapy in advanced malignancies. Indian Journal of Cancer 0:0, pages 0.
Crossref
Crossref
B.N. Gurmikov, V.A. Vishnevsky, Yu.A. Kovalenko & A.V. Chzhao. (2020) Long-term results of surgical treatment of intrahepatic cholangiocarcinoma. Khirurgiya. Zhurnal im. N.I. Pirogova:5, pages 5.
Crossref
Crossref
Dongkai Zhou, Bingqiang Gao, Qifan Yang, Yang Kong & Weilin Wang. (2019) Integrative Analysis of ceRNA Network Reveals Functional lncRNAs in Intrahepatic Cholangiocarcinoma. BioMed Research International 2019, pages 1-9.
Crossref
Crossref
Chang Gok Woo, Ok-Jun Lee, Yaewon Yang, Yong June Kim, Jisun Lee & Seung-Myoung Son. (2019) Collision tumor comprising metastatic cholangiocarcinoma and seminoma in an undescended testis: a case report. Journal of International Medical Research 47:11, pages 5809-5816.
Crossref
Crossref
Cinthya Santos Cirqueira, Aloisio Sousa Felipe-Silva, Alda Wakamatsu, Lidiane Vieira Marins, Eziel Cavalcanti Rocha, Evandro Sobroza de Mello & Venâncio Avancini Ferreira Alves. (2018) Immunohistochemical Assessment of the Expression of Biliary Transportation Proteins MRP2 and MRP3 in Hepatocellular Carcinoma and in Cholangiocarcinoma. Pathology & Oncology Research 25:4, pages 1363-1371.
Crossref
Crossref
Amanda Bailey & Shimul A. Shah. (2019) Screening high risk populations for cancer: Hepatobiliary. Journal of Surgical Oncology 120:5, pages 847-850.
Crossref
Crossref
Cortlandt M. Sellers, Johannes Uhlig, Johannes M. Ludwig, Stacey M. Stein & Hyun S. Kim. (2019) Inflammatory markers in intrahepatic cholangiocarcinoma: Effects of advanced liver disease. Cancer Medicine 8:13, pages 5916-5929.
Crossref
Crossref
Zhangjun Cheng, Zhengqing Lei & Feng Shen. (2019) Coming of a precision era of the staging systems for intrahepatic cholangiocarcinoma?. Cancer Letters 460, pages 10-17.
Crossref
Crossref
Kensuke Sugiura, Takashi Mishima, Shigetsugu Takano, Hideyuki Yoshitomi, Katsunori Furukawa, Tsukasa Takayashiki, Satoshi Kuboki, Mamoru Takada, Masaru Miyazaki & Masayuki Ohtsuka. (2019) The Expression of Yes-Associated Protein (YAP) Maintains Putative Cancer Stemness and Is Associated with Poor Prognosis in Intrahepatic Cholangiocarcinoma. The American Journal of Pathology 189:9, pages 1863-1877.
Crossref
Crossref
Vincenzo Di Nunno, Giorgio Frega, Matteo Santoni, Lidia Gatto, Michelangelo Fiorentino, Rodolfo Montironi, Nicola Battelli, Giovanni Brandi & Francesco Massari. (2019) BAP1 in solid tumors. Future Oncology 15:18, pages 2151-2162.
Crossref
Crossref
B. N. Gurmikov, Yu. A. Kovalenko, V. A. Vishnevsky & A. V. Chzhao. (2019) Molecular genetic aspects of intrahepatic cholangiocarcinoma: literature review. Advances in molecular oncology 6:1, pages 37-43.
Crossref
Crossref
Kota Sahara, Diamantis I. Tsilimigras, Rittal Mehta, Fabio Bagante, Alfredo Guglielmi, Luca Aldrighetti, Sorin Alexandrescu, Hugo P. Marques, Feng Shen, Bas G. Koerkamp, Itaru Endo & Timothy M. Pawlik. (2019) A novel online prognostic tool to predict long‐term survival after liver resection for intrahepatic cholangiocarcinoma: The “metro‐ticket” paradigm. Journal of Surgical Oncology.
Crossref
Crossref
Anuhya Kommalapati, Sri Harsha Tella, Gaurav Goyal, Mitesh Borad, Steven R. Alberts, Lewis Roberts, Joleen M. Hubbard, Lori Durgin, Sean Cleary & Amit Mahipal. (2019) Association between treatment facility volume, therapy types and overall survival in patients with intrahepatic cholangiocarcinoma. HPB 21:3, pages 379-386.
Crossref
Crossref
B. N. Gurmikov, Yu. A. Kovalenko, V. A. Vishnevsky & A. V. Chzhao. (2019) Intrahepatic cholangiocellular carcinoma: diagnosis and treatment (review). Annaly khirurgicheskoy gepatologii = Annals of HPB surgery 23:4, pages 108-117.
Crossref
Crossref
S. Tavolari, M. Deserti, F. Vasuri, S. Curti, A. Palloni, A.D. Pinna, M. Cescon, G. Frega, S. De Lorenzo, M.A. Barbera, I. Garajova, L. Ricciardiello, D. Malvi, A. D'Errico-Grigioni, M.A. Pantaleo & G. Brandi. (2019) Membrane human equilibrative nucleoside transporter 1 is associated with a high proliferation rate and worse survival in resected intrahepatic cholangiocarcinoma patients not receiving adjuvant treatments. European Journal of Cancer 106, pages 160-170.
Crossref
Crossref
Ken Nagata, Takahiro Einama, Akifumi Kimura, Michinori Murayama, Hiroteru Takeo, Makoto Nishikawa, Mayumi Hoshikawa, Takuji Noro, Sho Ogata, Suefumi Aosasa, Yoshiki Kajiwara, Eiji Shinto, Yoshihisa Yaguchi, Shuichi Hiraki, Hironori Tsujimoto, Kazuo Hase, Hideki Ueno & Junji Yamamoto. (2018) A case of intrahepatic cholangiocarcinoma that was difficult to diagnose prior to surgery: A case report. Oncology Letters.
Crossref
Crossref
Kazunari Sasaki, Georgios A. Margonis, Nikolaos Andreatos, Qinyu Chen, Carlotta Barbon, Fabio Bagante, Matthew Weiss, Irinel Popescu, Hugo P. Marques, Luca Aldrighetti, Shishir K. Maithel, Carlo Pulitano, Todd W. Bauer, Feng Shen, George A. Poultsides, Olivier Soubrane, Guillaume Martel, Bas Groot Koerkamp, Alfredo Guglielmi, Itaru Endo, Federico N. Aucejo & Timothy M. Pawlik. (2018) Serum tumor markers enhance the predictive power of the AJCC and LCSGJ staging systems in resectable intrahepatic cholangiocarcinoma. HPB 20:10, pages 956-965.
Crossref
Crossref
Stefan Buettner, Gaya Spolverato, Charles W. Kimbrough, Sorin Alexandrescu, Hugo P. Marques, Jorge Lamelas, Luca Aldrighetti, T. Clark Gamblin, Shishir K. Maithel, Carlo Pulitano, Matthew Weiss, Todd W. Bauer, Feng Shen, George A. Poultsides, J. Wallis Marsh, Jan N.M. IJzermans, Bas Groot Koerkamp & Timothy M. Pawlik. (2018) The impact of neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio among patients with intrahepatic cholangiocarcinoma. Surgery 164:3, pages 411-418.
Crossref
Crossref
Daniel Jesper, Sabrina G. Heyn, Barbara Schellhaas, Lukas Pfeifer, Ruediger S. Goertz, Steffen Zopf, Markus F. Neurath & Deike Strobel. (2018) Effects of liver cirrhosis and patient condition on clinical outcomes in intrahepatic cholangiocarcinoma. European Journal of Gastroenterology & Hepatology 30:5, pages 552-556.
Crossref
Crossref
Yurie Soejima, Miho Takeuchi, Takumi Akashi, Motoji Sawabe & Toshio Fukusato. (2018) β4 and β6 Integrin Expression Is Associated with the Subclassification and Clinicopathological Features of Intrahepatic Cholangiocarcinoma. International Journal of Molecular Sciences 19:4, pages 1004.
Crossref
Crossref
Xu-Feng Zhang, Jeffery Chakedis, Fabio Bagante, Eliza W. Beal, Yi Lv, Matthew Weiss, Irinel Popescu, Hugo P. Marques, Luca Aldrighetti, Shishir K. Maithel, Carlo Pulitano, Todd W. Bauer, Feng Shen, George A. Poultsides, Oliver Soubrane, Guillaume Martel, B. Groot Koerkamp, Alfredo Guglielmi, Endo Itaru & Timothy M. Pawlik. (2017) Implications of Intrahepatic Cholangiocarcinoma Etiology on Recurrence and Prognosis after Curative-Intent Resection: a Multi-Institutional Study. World Journal of Surgery 42:3, pages 849-857.
Crossref
Crossref
Xia Wu, Ran Chen, Weiliang Zheng & Hongjie Hu. (2018) Comprehensive Analysis of Factors Affecting Clinical Response and Short-Term Survival to Drug-Eluting Bead Transarterial Chemoembolization for Treatment in Patients With Liver Cancer. Technology in Cancer Research & Treatment 17, pages 153303381875987.
Crossref
Crossref
Nikitha Murali, Lynn Jeanette Savic, Nariman Nezami, Julius Chapiro & Jean-François Geschwind. 2018. Primary and Metastatic Liver Tumors. Primary and Metastatic Liver Tumors
111
123
.
Qiang Kang, Hao Zou, Xuan Yang, Jia‑Bin Cai, Li‑Xin Liu, Nan Xie, Lian‑Min Wang, Yue‑Hua Li & Xiao‑Wen Zhang. (2017) Characterization and prognostic significance of mortalin, Bcl‑2 and Bax in intrahepatic cholangiocarcinoma. Oncology Letters.
Crossref
Crossref
Stefan Buettner, Boris Galjart, Jeroen L. A. van Vugt, Fabio Bagante, Sorin Alexandrescu, Hugo P. Marques, Jorge Lamelas, Luca Aldrighetti, T. Clark Gamblin, Shishir K. Maithel, Carlo Pulitano, Georgios A. Margonis, Matthew Weiss, Todd W. Bauer, Feng Shen, George A. Poultsides, J. Wallis Marsh, Jan N. M. IJzermans, Bas Groot Koerkamp & Timothy M. Pawlik. (2017) Performance of prognostic scores and staging systems in predicting long-term survival outcomes after surgery for intrahepatic cholangiocarcinoma. Journal of Surgical Oncology 116:8, pages 1085-1095.
Crossref
Crossref